Bristol-Myers Squibb (BMY) Insider Trading & Ownership $47.63 +0.06 (+0.13%) Closing price 03:59 PM EasternExtended Trading$46.78 -0.85 (-1.78%) As of 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Bristol-Myers Squibb (NYSE:BMY) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.09%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$402,234.42Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$38,934.00 Get BMY Insider Trade Alerts Want to know when executives and insiders are buying or selling Bristol-Myers Squibb stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BMY Insider Buying and Selling by Quarter Bristol-Myers Squibb Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/25/2025Samit HirawatEVPBuy4,250$47.58$202,215.00 3/27/2025Greg LandsmanU.S. Congress Member (D-OH)Sell$58.90$1,001 - $15,0002/14/2025Samit HirawatEVPBuy1,823$54.84$99,973.32 1/15/2025Julie JohnsonU.S. Congress Member (D-TX)Buy$55.96$1,001 - $15,00012/6/2024Virginia FoxxU.S. Congress Member (R-NC)Buy$59.38$1,001 - $15,00011/4/2024Phil M HolzerSVPSell700$55.62$38,934.00 11/1/2024Samit HirawatEVPBuy1,830$54.67$100,046.10 (Data available from 1/1/2013 forward) BMY Insider Trading Activity - Frequently Asked Questions Who is on Bristol-Myers Squibb's Insider Roster? The list of insiders at Bristol-Myers Squibb includes Ann Powell, Christopher S Boerner, David V Elkins, Giovanni Caforio, Phil M Holzer, Robert M Plenge, Rupert Vessey, Samit Hirawat, Sandra Leung, and Theodore R Samuels II. Learn more on insiders at BMY. What percentage of Bristol-Myers Squibb stock is owned by insiders? 0.09% of Bristol-Myers Squibb stock is owned by insiders. Learn more on BMY's insider holdings. Which Bristol-Myers Squibb insiders have been buying company stock? The following insiders have purchased BMY shares in the last 24 months: Christopher S Boerner ($249,609.06), Samit Hirawat ($402,234.42), and Theodore R Samuels II ($423,385.00). How much insider buying is happening at Bristol-Myers Squibb? Insiders have purchased a total of 21,474 BMY shares in the last 24 months for a total of $1,075,228.48 bought. Which Bristol-Myers Squibb insiders have been selling company stock? The following insiders have sold BMY shares in the last 24 months: Ann Powell ($1,101,642.50), Phil M Holzer ($38,934.00), and Robert M Plenge ($44,754.48). How much insider selling is happening at Bristol-Myers Squibb? Insiders have sold a total of 19,418 Bristol-Myers Squibb shares in the last 24 months for a total of $1,185,330.98 sold. Which members of congress are trading Bristol-Myers Squibb? Julie Johnson (D-TX) and Virginia Foxx (R-NC) have bought shares of Bristol-Myers Squibb in the last year totaling $16,000. Greg Landsman (D-OH) has sold shares totaling $8,000. Bristol-Myers Squibb Key ExecutivesDr. Christopher S. Boerner Ph.D. (Age 53)CEO & Chairman Compensation: $3.14MMr. David V. Elkins (Age 56)Executive VP & CFO Compensation: $2.28MMs. Sandra Leung Esq. (Age 63)Executive VP & General Counsel Compensation: $2.58MMr. Samit Hirawat M.D. (Age 55)Executive VP, Chief Medical Officer & Head of Development Compensation: $2.62M2 recent tradesMr. Greg Meyers (Age 51)Executive VP and Chief Digital & Technology Officer Mr. Timothy PowerVP & Head of Investor RelationsMs. Kimberly M. JablonskiChief Compliance & Ethics OfficerMs. Ahn Amanda Poole (Age 49)Executive Vice President & Chief Human Resources Officer Dr. Joseph J. Eiden Jr. (Age 75)Head of Medical Affairs Mr. Adam Lenkowsky (Age 52)Executive VP, Chief Commercialization Officer & Head of U.S. Oncology More Insider Trading Tools from MarketBeat Related Companies Johnson & Johnson Insider Buying AbbVie Insider Buying Merck & Co., Inc. Insider Buying Pfizer Insider Buying Zoetis Insider Buying Royalty Pharma Insider Buying Corcept Therapeutics Insider Buying Jazz Pharmaceuticals Insider Buying Perrigo Insider Buying Supernus Pharmaceuticals Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Top-Ranked Insider Buys From April by Market CapMcDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You? This page (NYSE:BMY) was last updated on 5/7/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bristol-Myers Squibb Please log in to your account or sign up in order to add this asset to your watchlist. Share Bristol-Myers Squibb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BMY Stock Free BMY Stock Alerts